rosiglitazone has been researched along with 1,3-dihydroxy-xanthone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, CY; Cheng, XN; Ding, SM; Huang, ZX; Lan, T; Wang, B; Xie, ML; Ye, GJ | 1 |
1 other study(ies) available for rosiglitazone and 1,3-dihydroxy-xanthone
| Article | Year |
|---|---|
Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
Topics: alpha-Glucosidases; Binding Sites; Drug Design; Glucose; Glycoside Hydrolase Inhibitors; Hep G2 Cells; Hepatocytes; Humans; Hypoglycemic Agents; Kinetics; Molecular Docking Simulation; Molecular Structure; Protein Binding; Structure-Activity Relationship; Triazoles; Xanthones | 2019 |